Deborah DiSanzo - Novanta Independent Director
| 1GSN Stock | EUR 159.00 6.00 3.64% |
Insider
Deborah DiSanzo is Independent Director of Novanta since 2019.
| Age | 59 |
| Tenure | 5 years |
| Phone | 781 266 5700 |
| Web | https://www.novanta.com |
Novanta Management Efficiency
The company has return on total asset (ROA) of 0.0534 % which means that it generated a profit of $0.0534 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1392 %, meaning that it generated $0.1392 on every $100 dollars invested by stockholders. Novanta's management efficiency ratios could be used to measure how well Novanta manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| David Slinkman | Quaker Chemical | 58 | |
| Stephen Jones | ScanSource | 51 | |
| Shane Hostetter | Quaker Chemical | 42 | |
| Dhruwa Rai | Quaker Chemical | 54 | |
| Joseph Berquist | Quaker Chemical | 52 | |
| Futoshi Kamiwaki | Sekisui Chemical Co | 63 | |
| Michael Baur | ScanSource | 66 | |
| Katsunori Mukai | Sekisui Chemical Co | N/A | |
| Jeffrey Schnell | Quaker Chemical | N/A | |
| Naoko Fukutomi | Sekisui Chemical Co | N/A | |
| John Eldh | ScanSource | 55 | |
| Wilbert Platzer | Quaker Chemical | 62 | |
| Andrew Tometich | Quaker Chemical | 56 | |
| Robert Esq | Quaker Chemical | 58 | |
| Rachel Hayden | ScanSource | N/A | |
| Tatsuya Nishida | Sekisui Chemical Co | N/A | |
| Ikusuke Shimizu | Sekisui Chemical Co | 59 | |
| Mary Gentry | ScanSource | N/A | |
| Toshiyuki Kamiyoshi | Sekisui Chemical Co | 62 | |
| Jason Weidman | ScanSource | N/A | |
| Meiko Koga | Sekisui Chemical Co | N/A | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0534 |
Novanta Leadership Team
Elected by the shareholders, the Novanta's board of directors comprises two types of representatives: Novanta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novanta. The board's role is to monitor Novanta's management team and ensure that shareholders' interests are well served. Novanta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novanta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Bershad, Independent Chairman of the Board | ||
| Ray Nash, Corp Leader | ||
| Michele Welsh, Gen Sec | ||
| Sarah Betadam, Chief Officer | ||
| Deborah Eldracher, Independent Director | ||
| Heinrich Dreyer, Group Vision | ||
| Ira Lamel, Independent Director | ||
| Lonny Carpenter, Independent Director | ||
| Brian King, Independent Director | ||
| Peter Chang, Co Officer | ||
| Brian Young, Chief Human Resource Officer | ||
| Charlie Webster, Ex Chain | ||
| Thomas Secor, Independent Director | ||
| Deborah DiSanzo, Independent Director | ||
| Matthijs Glastra, Chief Executive Officer, Director | ||
| Chuck Ravetto, Group Group | ||
| Robert Buckley, Chief Financial Officer |
Novanta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novanta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0534 | |||
| Current Valuation | 5.53 B | |||
| Shares Outstanding | 35.69 M | |||
| Shares Owned By Insiders | 0.85 % | |||
| Shares Owned By Institutions | 99.15 % | |||
| Price To Earning | 134.04 X | |||
| Price To Book | 9.99 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 706.79 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Novanta Stock
When determining whether Novanta is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Novanta Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Novanta Stock. Highlighted below are key reports to facilitate an investment decision about Novanta Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Novanta. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Novanta Stock please use our How to Invest in Novanta guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.